Literature DB >> 8871469

Cardioversion of atrial fibrillation.

O M Jolobe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871469      PMCID: PMC2398366          DOI: 10.1136/pgmj.72.844.126

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  13 in total

1.  Factors determining success and energy requirements for cardioversion of atrial fibrillation: revised version.

Authors:  G W Dalzell; J Anderson; A A Adgey
Journal:  Q J Med       Date:  1991-01

Review 2.  Digoxin for atrial fibrillation: a drug whose time has gone?

Authors:  R H Falk; J I Leavitt
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

3.  Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study.

Authors:  I W Black; D Fatkin; K B Sagar; B K Khandheria; D Y Leung; J M Galloway; M P Feneley; W F Walsh; R A Grimm; C Stollberger
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

4.  Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

Authors:  B F Uretsky; J B Young; F E Shahidi; L G Yellen; M C Harrison; M K Jolly
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

5.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

6.  Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease.

Authors:  I C Van Gelder; H J Crijns; P K Blanksma; M L Landsman; J L Posma; M P Van Den Berg; F L Meijler; K I Lie
Journal:  Am J Cardiol       Date:  1993-09-01       Impact factor: 2.778

7.  Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients.

Authors:  I W Black; A P Hopkins; L C Lee; W F Walsh
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

8.  Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial.

Authors:  R H Falk; A A Knowlton; S A Bernard; N E Gotlieb; N J Battinelli
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

9.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

10.  Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial.

Authors:  A W Hamer; L B Arkles; J A Johns
Journal:  J Am Coll Cardiol       Date:  1989-12       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.